180 related articles for article (PubMed ID: 8719552)
21. Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management.
Bridoux F; Javaugue V; Bender S; Leroy F; Aucouturier P; Debiais-Delpech C; Goujon JM; Quellard N; Bonaud A; Clavel M; Trouillas P; Di Meo F; Gombert JM; Fermand JP; Jaccard A; Cogné M; Touchard G; Sirac C
Kidney Int; 2017 Feb; 91(2):423-434. PubMed ID: 27773425
[TBL] [Abstract][Full Text] [Related]
22. [Fibrillary glomerulonephritis of the nodular glomerulosclerosis variety].
Rosenberg H; Delucchi C
Rev Med Chil; 1994 Feb; 122(2):193-7. PubMed ID: 8085085
[TBL] [Abstract][Full Text] [Related]
23. A case of monoclonal immunoglobulin light- and heavy-chain deposition disease exhibiting atypical deposition with fibrillary structures, successfully treated with chemotherapy.
Nakatsuka A; Maeshima Y; Sarai A; Yanai H; Sugiyama H; Yamasaki Y; Makino H
Clin Nephrol; 2005 Sep; 64(3):221-7. PubMed ID: 16175947
[TBL] [Abstract][Full Text] [Related]
24. The combination of thrombotic microangiopathy and nodular sclerosis in light chain deposition disease.
Kanjanabuch T; Bunruang R; Srisawat N; Lewsuwan S; Kittikovit V; Eiam-Ong S
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S248-52. PubMed ID: 17044479
[TBL] [Abstract][Full Text] [Related]
25. A case of immunotactoid glomerulopathy with unusual microtubular deposits.
Mukai K; Kitazawa K; Totsuka D; Saito K; Sugisaki T
Clin Nephrol; 1998 May; 49(5):321-4. PubMed ID: 9617498
[TBL] [Abstract][Full Text] [Related]
26. Immunoglobulin light (heavy)-chain deposition disease: from molecular medicine to pathophysiology-driven therapy.
Ronco P; Plaisier E; Mougenot B; Aucouturier P
Clin J Am Soc Nephrol; 2006 Nov; 1(6):1342-50. PubMed ID: 17699367
[TBL] [Abstract][Full Text] [Related]
27. Long-term renal survival of γ3-heavy chain deposition disease: a case report.
Katsuno T; Mizuno S; Mabuchi M; Tsuboi N; Komatsuda A; Maruyama S
BMC Nephrol; 2017 Jul; 18(1):239. PubMed ID: 28716013
[TBL] [Abstract][Full Text] [Related]
28. [High molecular-weight Bence Jones protein deposits in the kidney of a patient with plasma cell dyscrasia].
Kitabayashi A; Komatsuda A; Miura AB; Yamaguchi A; Takatsu H; Fujita K
Rinsho Ketsueki; 2000 Apr; 41(4):341-6. PubMed ID: 10846466
[TBL] [Abstract][Full Text] [Related]
29. Unusual gamma heavy chain disease protein in a patient with splenic marginal-zone lymphoma.
Morita K; Kawamoto H; Takada H; Nakamura S; Ishii K; Okamoto Y
Ann Clin Biochem; 2006 Mar; 43(Pt 2):161-4. PubMed ID: 16536920
[TBL] [Abstract][Full Text] [Related]
30. Gamma heavy chain disease screening showing a discrepancy between electrophoretic and nephelometric determinations of serum gamma globulin concentration.
Takatani T; Morita K; Takaoka N; Tatsumi M; Okuno Y; Masutani T; Murakawa K; Fukui A; Tsukaguchi N; Okamoto Y
Ann Clin Biochem; 2002 Sep; 39(Pt 5):531-3. PubMed ID: 12227865
[TBL] [Abstract][Full Text] [Related]
31. Tubulointerstitial nephritis accompanying gamma-heavy chain deposition and gamma-heavy chain restricted plasma cells in the kidney.
Nayer A; Green DF; Gonzalez-Suarez ML; Sujoy V; Ikpatt OF; Thomas DB
Iran J Kidney Dis; 2014 Sep; 8(5):417-23. PubMed ID: 25194410
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal immunoglobulin deposition disease associated with membranous features.
Komatsuda A; Masai R; Ohtani H; Togashi M; Maki N; Sawada K; Wakui H
Nephrol Dial Transplant; 2008 Dec; 23(12):3888-94. PubMed ID: 18596130
[TBL] [Abstract][Full Text] [Related]
33. Morphologic heterogeneity of renal light-chain deposition disease.
Gokden N; Barlogie B; Liapis H
Ultrastruct Pathol; 2008; 32(1):17-24. PubMed ID: 18300034
[TBL] [Abstract][Full Text] [Related]
34. Cast nephropathy in mu heavy chain disease.
Preud'homme JL; Bauwens M; Dumont G; Goujon JM; Dreyfus B; Touchard G
Clin Nephrol; 1997 Aug; 48(2):118-21. PubMed ID: 9285150
[TBL] [Abstract][Full Text] [Related]
35. Renal crescentic alpha heavy chain deposition disease: a report of 3 cases and review of the literature.
Alexander MP; Nasr SH; Watson DC; Méndez GP; Rennke HG
Am J Kidney Dis; 2011 Oct; 58(4):621-5. PubMed ID: 21944962
[TBL] [Abstract][Full Text] [Related]
36. Nodular glomerulosclerosis of unknown origin associated with the nephrotic syndrome.
Suzuki S; Maruyama Y; Nakamura T; Ueno M; Nishi S; Ooshima A; Isemura M; Arakawa M
Nephron; 1994; 66(4):462-9. PubMed ID: 8015653
[TBL] [Abstract][Full Text] [Related]
37. Fibrillary glomerulopathy secondary to light chain deposition disease in a patient with monoclonal gammopathy.
Sundaram S; Mainali R; Norfolk ER; Shaw JH; Zhang PL
Ann Clin Lab Sci; 2007; 37(4):370-4. PubMed ID: 18000296
[TBL] [Abstract][Full Text] [Related]
38. [Pathological features of light chain nephropathy].
Wang SX; Zou WZ; Zhang Y; Wang SH; Chai LJ; Tang XY
Zhonghua Bing Li Xue Za Zhi; 2003 Dec; 32(6):506-10. PubMed ID: 14761593
[TBL] [Abstract][Full Text] [Related]
39. Heavy Chain Deposition Disease: Clinicopathologic Characteristics of a Chinese Case Series.
Zhang Y; Li X; Liang D; Xu F; Liang S; Zhu X; Zheng N; Huang X; Liu Z; Zeng C
Am J Kidney Dis; 2020 May; 75(5):736-743. PubMed ID: 31699519
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal immunoglobulin G1-kappa fibrillary glomerulonephritis.
Grove P; Neale PH; Peck M; Schiller B; Haas M
Mod Pathol; 1998 Jan; 11(1):103-9. PubMed ID: 9556416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
